Remote, semiautomated production of 6-[18F]fluoro-l-dopa for human studies with PET
β Scribed by Andre Luxen; Milton Perlmutter; Gerald T. Bida; Glenn Van Moffaert; Joseph S. Cook; Nagichettiar Satyamurthy; Michael E. Phelps; Jorge R. Barrio
- Publisher
- Elsevier Science
- Year
- 1990
- Weight
- 664 KB
- Volume
- 41
- Category
- Article
- ISSN
- 0883-2889
No coin nor oath required. For personal study only.
β¦ Synopsis
Regioselective radiofluorodemercuration of the 6-mercurio derivative 5 with [18F]acetylhypofluorite afforded, after acidic hydrolysis, 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine (6-FD, 1) with a radiochemical yield of 11% (decay corrected and based on the total amount of [18F]F2 recovered from the target). 6-FD was obtained with a chemical and radiochemical purity of greater than 99% and with a level of mercury in the final preparation of less than 20 ppb. Utilization of a remote, semiautomated production system, resulted in the preparation of a sterile, pyrogen-free product suitable for human injection after a synthesis time of 50 min.
π SIMILAR VOLUMES
## Abstract The aim of this study was to investigate the rate of progression in Parkinson's disease (PD) with 6β[^18^F]fluoroβLβdopa (FDOPA) positron emission tomography (PET). We investigated 21 patients with PD and eight healthy controls. Ten of the patients were de novo at the time of the first
A detailed and improved synthetic procedure to produce NCA 6-['"F]fluoro-L-dopa (6-FDOPA) is described. A remotely-operable system for its routine production was built and tested for stable and reproducible tracer production (n > 20). Commercially available 6-nitroveratraldehyde or 6-nitropiperonal
This report describes a method to assess, in vivo, the turnover of dopamine (DA) and describes its application to the evaluation of DA function in normal monkeys and monkeys with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced lesions of the DA nigro-striatal pathway. Using positron emis